Arina Kurochkina

EDUCATION

College / University

Lomonosov Moscow State University

Highest Degree

Bachelor of Science

Major Subjects

Biotechnology, Molecular Biology

Country

Russian Federation

Lab Experience

Techniques in cell biology (cultivation, cryo-conservation, transfection, transduction); nucleic acids methods (purification, amplification, plasmid construction, agarose and PAA gel electrophoresis, cloning via transformation in E. coli, RNA in vitro transcription); protein methods (SDS-PAGE, Western Blotting), ELISA, encapsulation RNA in lipid nanoparticles.

Projects / Research

2022 – 2023: “Development of a platform for the creation of mRNA vaccines against viral infections, a case study of COVID-19” at the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Laboratory of Molecular Oncology by O. Dontsova, M. Rubtsova group
2020 – 2022: “Searching for small open reading frames in the human genome” at the Belozersky Research Institute of Physical and Chemical Biology, O. Dontsova’s laboratory of “Structure and function of ribonucleic acids”, N. Shepelev group

Scholarships / Awards

2023 – 2024:	Stipend by the International Max Planck Research School
2022 – 2023:	State scholarship for cultural and creative achievements
2019 – 2023:	Increased scholarship for academic achievements by Lomonosov Moscow State University

SCIENTIFIC INTERESTS AND GOALS

I am interested in several areas in science, which I recognize as the most cutting-edge. I consider epigenome to be an intriguing enigma, as epigenetic disorders are often found to be reasons for many diseases, but still, we do not have accurate information on their mechanisms, nor tools for their regulation. I would like to study such processes in detail, especially in terms of substantial illnesses like cancer or neurodegenerative diseases. I also want to incorporate my previous experience with RNA into my future research, as I suspect that this molecule can make a significant contribution to epigenetic processes, and I am inspired to work with it.